Roncero Carlos, Bravo-Grande José Lorenzo, Andrés-Olivera Pilar, Peña Marta, Treceño Carlos, González-Pelaez Pilar, Aguilar Lourdes, Remón-Gallo Diego, González-Sánchez Armando
Department of Health Sciences, Miguel de Cervantes European University (UEMC), Valladolid (Spain), C. del Padre Julio Chevalier, 2, 47012 Valladolid, Spain.
Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Virgen de la Vega, 10 ª Planta, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
J Clin Med. 2025 Jun 16;14(12):4266. doi: 10.3390/jcm14124266.
: Benzodiazepines (BZDs), commonly used to treat insomnia and anxiety, are increasingly used in Spain, raising concerns due to their potential for abuse and dependence. This study investigates the use of BZDs and other psychotropic medications among healthcare workers, exploring their prevalence, associated factors, and their relationship with mental health issues following the COVID-19 pandemic. : An anonymous online survey was conducted among healthcare workers at the Salamanca University Healthcare Complex (CAUSA) from March 2023 to January 2024. Of 1121 participants, 685 provided complete responses, which were analysed. Insomnia, anxiety, and depression were assessed using the Insomnia Severity Index (ISI) and Patient Health Questionnaire-4 (PHQ-4). : Of the respondents, 23.8% reported using sleep medication, with 27.8% doing so without a prescription. Additionally, 14.7% used medication for depression or anxiety, with only 0.6% without a prescription. Hypnotic medicine use was associated with older age, insomnia, anxiety, depression, psychological or psychiatric treatment, COVID-19 after-effects, and diagnosed sleep disorders. Night-shift work was associated with increased hypnotic medication use in men but not in women. The use of these medications was linked to a reduced quality of life and impaired work performance. : The use of BZD and self-medication are prevalent among healthcare professionals, exceeding the rates observed in the general population. These findings highlight the urgent need for targeted interventions to address psychotropic medication use, promote other pharmacological and non-pharmacological alternatives for insomnia, and enhance mental health support for this vulnerable population.
苯二氮䓬类药物（BZDs）常用于治疗失眠和焦虑，在西班牙的使用越来越多，因其潜在的滥用和依赖可能性而引发担忧。本研究调查了医护人员中BZDs及其他精神药物的使用情况，探讨其流行程度、相关因素以及在2019冠状病毒病大流行后与心理健康问题的关系。：2023年3月至2024年1月，对萨拉曼卡大学医疗综合中心（CAUSA）的医护人员进行了一项匿名在线调查。在1121名参与者中，685人提供了完整回复并进行了分析。使用失眠严重程度指数（ISI）和患者健康问卷-4（PHQ-4）评估失眠、焦虑和抑郁情况。：在受访者中，23.8%报告使用助眠药物，其中27.8%是在没有处方的情况下使用。此外，14.7%使用治疗抑郁或焦虑的药物，只有0.6%是在没有处方的情况下使用。使用催眠药物与年龄较大、失眠、焦虑、抑郁、心理或精神治疗、2019冠状病毒病后遗症以及确诊的睡眠障碍有关。夜班工作与男性使用催眠药物增加有关，但与女性无关。使用这些药物与生活质量下降和工作表现受损有关。：BZD的使用和自我用药在医护人员中很普遍，超过了普通人群中的观察率。这些发现凸显了采取针对性干预措施以解决精神药物使用问题、推广其他治疗失眠的药物和非药物替代方法以及加强对这一弱势群体心理健康支持的迫切需求。
